← FDA Drug Approvals (Drugs@FDA)
SUGAMMADEX
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMS INC · Approved 2024-11-20
Drug application
- FDA Application #
ANDA213915- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUGAMMADEX
- Generic name
- Sugammadex
- Active ingredients
- SUGAMMADEX
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- None (Tentative Approval)
- Sponsor
- MYLAN PHARMS INC
- First approval
- 2024-11-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown